What key counseling point should patients be aware of regarding Olmesartan?

Olmesartan is an angiotensin II receptor blocker (ARB) commonly used to treat hypertension. One vital counseling point for patients taking Olmesartan is the risk associated with pregnancy. It is important for patients, especially women of childbearing age, to understand that Olmesartan can cause harm to the developing fetus if taken during pregnancy. The medication is classified as a Category D drug, indicating that there is evidence of risk to the fetus based on human data. Therefore, patients should be advised to avoid becoming pregnant while on this medication and to discuss any potential pregnancy plans with their healthcare provider.

Understanding the implications of taking Olmesartan during pregnancy can help patients make informed decisions about their treatment and prevent harm to an unborn child. This awareness is crucial, as many patients may not consider the effects of their medications when planning for pregnancy.